2018 $4 Billion Dermal Facial Fillers Market - Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2017-2023 - ResearchAndMarkets.com

January 10, 2019

DUBLIN--(BUSINESS WIRE)--Jan 10, 2019--The “Dermal Facial Fillers Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2018-2023” report has been added to ResearchAndMarkets.com’s offering.

The global dermal facial fillers market reached a value of US$ 2.1 Billion in 2017

The dermal facial fillers market is strongly being driven by an increase in the number of people seeking treatment for facial wrinkles and scarring. This increase has occurred on account of a continuous rise in an imbalance diet, stress and insomnia.

Another major driver of this market is the fact that this treatment is non-invasive and has does not take a long period of time to be conducted. Moreover, there has been a decrease in the number of complexities which occur post-surgery.

In addition to this, the surgery does not have a prominent scarring as it requires very small incisions which has positively influenced the overall growth of the market.

Other factors that are catalysing the growth of this market include a rising ageing population, increasing disposable incomes and raising awareness through social media platforms such as youtube and Instagram.

Looking forward, we expect this market to reach a value of US$ 4.0 Billion by 2023, exhibiting a CAGR of around 11% during 2018-2023.

Key Topics Covered:

1 Preface

2 Scope and Methodology

3 Executive Summary

4 Introduction

5 Global Dermal Facial Fillers Market

6 Market Breakup by Material Type

7 Market Breakup by Product Origin

8 Market Breakup by Region

9 Dermal Facial Fillers Manufacturing Process

10 Competitive Landscape

Allergan Galderma Merz Pharma AQTIS Medical Bioha Laboratories Cynosure Cosmoderm ColBar LifeScience Techderm Regenerative Medical System Suneva Medical Sanofi SciVision Biotech Speciality European Pharma Syneron Ulthera Visionmed.

For more information about this report visit https://www.researchandmarkets.com/research/pr9xvp/2018_4_billion?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20190110005293/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager


For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Dermatological Drugs



SOURCE: Research and Markets

Copyright Business Wire 2019.

PUB: 01/10/2019 06:25 AM/DISC: 01/10/2019 06:25 AM


Update hourly